Vaginal Sling Market Report 2025

The vaginal sling market size has grown strongly in recent years. It will grow from $1.49 billion in 2024 to $1.61 billion in 2025 at a compound annual growth rate (CAGR) of 8.2%. The growth in the historic period can be attributed to increasing prevalence of stress urinary incontinence, advancements in surgical techniques, rising aging population, regulatory approval, healthcare infrastructure development.

The vaginal sling market size is expected to see strong growth in the next few years. It will grow to $2.32 billion in 2029 at a compound annual growth rate (CAGR) of 9.6%. The growth in the forecast period can be attributed to growing demand for minimally invasive procedures, increasing healthcare expenditure, expanding geriatric population, patient preference for outpatient procedures, increasing awareness through marketing initiatives. Major trends in the forecast period include technological advancements, product innovations, minimally invasive procedures, global expansion and market penetration, patient-centric approaches.

The increasing female geriatric population is anticipated to drive the growth of the vaginal sling market in the future. The female geriatric population refers to individuals aged 65 and older. A segment of this growing population experiences stress urinary incontinence (SUI) and other forms of urinary incontinence, which can be treated and managed with vaginal slings. For example, in January 2023, a report published by Statistics Netherlands, a government agency in the Netherlands, indicated that the female population in the country totaled 2,172 residents. Among those aged 90 and above, there are 95,090 women compared to 40,128 men. Thus, the expanding female geriatric population is propelling the growth of the vaginal sling market.

Rising healthcare expenditure is expected to further stimulate the growth of the vaginal sling market. Healthcare expenditure encompasses the total costs of health care (including both public and private spending) expressed as a percentage of GDP. An increase in healthcare expenditure significantly contributes to the vaginal sling market's growth by promoting innovation, accessibility, education, and improved quality of care for individuals seeking treatment for stress urinary incontinence. For instance, in March 2022, the 2021-2030 National Health Expenditure (NHE) report released by the Centers for Medicare & Medicaid Services, a US federal agency, projected an average annual increase of 5.1% in national health spending from 2021 to 2030, reaching nearly $6.8 trillion. Additionally, it is expected that Medicare spending will rise at a 7.2% annual rate and Medicaid spending at a 5.6% annual rate during the same period. Therefore, the growing healthcare expenditure is driving the growth of the vaginal sling market.

Key players in the vaginal sling market are concentrating on creating innovative products such as Transvaginal Sling Systems to offer effective and safe surgical solutions for women experiencing stress urinary incontinence, thereby enhancing surgical flexibility and patient outcomes. The Transvaginal Sling System for Stress Urinary Incontinence (SUI) is a minimally invasive surgical technique that involves positioning a mesh sling beneath the urethra to provide support and prevent involuntary urine leakage during activities that elevate abdominal pressure, such as coughing or sneezing. For example, in March 2022, Caldera Medical, a US-based medical device firm, introduced the Desara TVez Transvaginal Sling System. This system includes a mesh implant designed to deliver steady and controlled support without tearing or curling, thereby improving the safety and efficacy of the surgical procedure for treating stress urinary incontinence (SUI). Its innovative design features enclosed dilator tips and a specially contoured introducer, which reduces tissue drag and simplifies the insertion process, ultimately enhancing patient outcomes and physician efficiency.

Leading companies in the vaginal slings market are developing innovative products, including treatments for stress urinary incontinence (SUI), to cater to larger customer bases, boost sales, and increase revenue. Treatments for Stress Urinary Incontinence (SUI) encompass various strategies aimed at addressing the underlying causes and managing the symptoms of involuntary urine leakage during activities such as coughing, sneezing, laughing, or physical exertion. For instance, in January 2024, UroCure LLC, a US-based women’s health company, partnered with LiNA Medical USA, a US-based minimally invasive gynecology device manufacturer, to launch two surgical solutions for female stress urinary incontinence: the ArcSP suprapubic sling system and the ArcTO transobturator sling system. The ArcSP system will provide a top-down, retropubic approach, while the ArcTO system will cater to surgeons preferring an outside-in, transobturator approach.

In February 2022, Evoco, a US-based biotechnology firm, acquired Agency for Medical Innovation (AMI) for an undisclosed sum. This acquisition allows Evoco to enhance its value creation potential and pursue next-level growth while collaborating closely with the existing management team. Agency for Medical Innovation is an Austria-based manufacturer specializing in vaginal slings.

Major companies operating in the vaginal sling market are Betatech Medical Inc., Boston Scientific Corporation, Caldera Medical Inc., Coloplast A/S, B. Braun Melsungen AG, Promedon GmbH, ABISS Pty Ltd., Lotus Surgicals Pvt. Ltd., UroCure LLC, Neomedic International Ltd., Ethicon Inc., Medtronic PLC, Cook Group Incorporated, Sofradim Production SAS, Medesign Pharmaceuticals Private Limited, MedGyn Products Inc., Medica Europe BV, Medline Industries Inc., Prosurg Inc., Degania Medical Devices Pvt. Ltd., SRS Medical Systems, Teleflex Inc., Urotech Co. Ltd., Urovision Diagnostics & Research Centre Private Limited, W.L. Gore & Associates Inc., Zimmer Biomet Holdings Inc., Johnson & Johnson Services Inc., CooperSurgical Inc.

North America was the largest region in the Vaginal Slings market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the vaginal sling market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the vaginal sling market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

A vaginal sling is a mesh implant designed to reinforce ligaments and connective tissues that aid in managing urine incontinence in females. The procedure involving a vaginal sling is one of the therapeutic options for addressing female stress urine incontinence.

Different types of vaginal slings are available, including transobturator slings, tension-free vaginal tape slings, and others. Transobturator slings are a surgical approach used to treat stress urinary incontinence, employing a thin strip of permanent mesh. These slings utilize various materials such as tissue slings and synthetic slings, catering to different types of urinary incontinence like stress urinary incontinence, urge urinary incontinence, and mixed urinary incontinence. Various end-users, including hospitals, clinics, and other medical facilities, utilize these products in their practice.

The vaginal sling market research report is one of a series of new reports that provides vaginal sling market statistics, including the vaginal sling industry’s global market size, regional shares, competitors with a vaginal sling market share, detailed vaginal sling market segments, market trends and opportunities, and any further data you may need to thrive in the vaginal sling industry. This vaginal sling market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The vaginal sling market consists of sales of allograft slings, mid-urethral retropubic slings, single-incision slings, and mini slings. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 3-5 business days.